- Home
- NGS vs ETON Comparison
NGS vs ETON Comparison
Compare NGS & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGS | ETON |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.9M | 498.8M |
| IPO Year | 2002 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NGS | ETON |
|---|---|---|
| Price | $32.50 | $16.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $35.67 | $29.67 |
| AVG Volume (30 Days) | 97.5K | ★ 282.6K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | ★ 14.85 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $166,824,000.00 | $70,316,000.00 |
| Revenue This Year | $9.50 | $113.27 |
| Revenue Next Year | $13.88 | $36.70 |
| P/E Ratio | $22.07 | ★ N/A |
| Revenue Growth | 9.53 | ★ 102.77 |
| 52 Week Low | $16.73 | $11.09 |
| 52 Week High | $33.82 | $23.00 |
Technical Indicators
Market Signals| Indicator | NGS | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 60.84 | 41.11 |
| Support Level | $31.63 | $16.13 |
| Resistance Level | $33.72 | $17.19 |
| Average True Range (ATR) | 1.01 | 0.73 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 63.72 | 31.94 |
Price Performance
Historical ComparisonAbout NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.